Withdrawal Study in people with Schizophrenia
This study is recruiting in the United States. It focuses on schizophrenia.
Multiple locations, including Rogers
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United States. It focuses on schizophrenia.
Multiple locations, including RogersThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Canada.
In MontrealThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on depression and currently lists participation information in China.
In Hong KongThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In BrocktonThis study is recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Canada.
In SherbrookeThis study is recruiting. It focuses on schizophrenia and currently lists participation information in France.
In ParisThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Canada.
In Scarborough VillageThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the Netherlands.
In NetherlandsThis study is recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.